129 related articles for article (PubMed ID: 3044367)
1. Ras oncogene mediated induction of a 92 kDa metalloproteinase; strong correlation with the malignant phenotype.
Ballin M; Gomez DE; Sinha CC; Thorgeirsson UP
Biochem Biophys Res Commun; 1988 Aug; 154(3):832-8. PubMed ID: 3044367
[TBL] [Abstract][Full Text] [Related]
2. Secretion of type IV collagenolytic protease and metastatic phenotype: induction by transfection with c-Ha-ras but not c-Ha-ras plus Ad2-E1a.
Garbisa S; Pozzatti R; Muschel RJ; Saffiotti U; Ballin M; Goldfarb RH; Khoury G; Liotta LA
Cancer Res; 1987 Mar; 47(6):1523-8. PubMed ID: 3028610
[TBL] [Abstract][Full Text] [Related]
3. Degradation of endothelial cell matrix collagen is correlated with induction of stromelysin by an activated ras oncogene.
LoSardo JE; Goggin BS; Bohoslawec O; Neri A
Clin Exp Metastasis; 1995 Jul; 13(4):236-48. PubMed ID: 7606886
[TBL] [Abstract][Full Text] [Related]
4. Ras levels and metalloproteinase activity in normal versus neoplastic rat mammary tissues.
Ballin M; Mackay AR; Hartzler JL; Nason A; Pelina MD; Thorgeirsson UP
Clin Exp Metastasis; 1991; 9(2):179-89. PubMed ID: 2032422
[TBL] [Abstract][Full Text] [Related]
5. Purification of a gelatin-degrading type IV collagenase secreted by ras oncogene-transformed fibroblasts.
Spinucci C; Zucker S; Wieman JM; Lysik RM; Imhof B; Ramamurthy N; Liotta LA; Nagase H
J Natl Cancer Inst; 1988 Nov; 80(17):1416-20. PubMed ID: 2845110
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of matrix metalloproteinases in activated c-ras-Ha-transfected immortalized human keratinocytes.
Meade-Tollin LC; Boukamp P; Fusenig NE; Bowen CP; Tsang TC; Bowden GT
Br J Cancer; 1998 Mar; 77(5):724-30. PubMed ID: 9514050
[TBL] [Abstract][Full Text] [Related]
7. Increased sensitivity of nontumorigenic fibroblasts expressing ras or myc oncogenes to malignant transformation induced by 5-aza-2'-deoxycytidine.
Rimoldi D; Srikantan V; Wilson VL; Bassin RH; Samid D
Cancer Res; 1991 Jan; 51(1):324-30. PubMed ID: 1703037
[TBL] [Abstract][Full Text] [Related]
8. Metastatic NIH 3T3 x LTA cell hybrids express 72 kDa type IV collagenase.
Xuan JW; Wilson SM; Chin JL; Chambers AF
Anticancer Res; 1995; 15(4):1227-33. PubMed ID: 7654002
[TBL] [Abstract][Full Text] [Related]
9. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
Su ZZ; Austin VN; Zimmer SG; Fisher PB
Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744
[TBL] [Abstract][Full Text] [Related]
10. Studies on the effects of laminin, E-8 fragment of laminin and synthetic laminin peptides PA22-2 and YIGSR on matrix metalloproteinases and tissue inhibitor of metalloproteinase expression.
Mackay AR; Gomez DE; Nason AM; Thorgeirsson UP
Lab Invest; 1994 Jun; 70(6):800-6. PubMed ID: 8015284
[TBL] [Abstract][Full Text] [Related]
11. Purification and characterization of a connective-tissue-degrading metalloproteinase from the cytosol of metastatic melanoma cells.
Zucker S; Turpeenniemi-Hujanen T; Ramamurthy N; Wieman J; Lysik R; Gorevic P; Liotta LA; Simon SR; Golub LM
Biochem J; 1987 Jul; 245(2):429-37. PubMed ID: 3663169
[TBL] [Abstract][Full Text] [Related]
12. Type IV collagenolytic activity linkage with the metastatic phenotype induced by ras transfection.
Garbisa S; Negro A; Kalebic T; Pozzatti R; Muschel R; Saffiotti U; Liotta LA
Adv Exp Med Biol; 1988; 233():179-86. PubMed ID: 2851926
[No Abstract] [Full Text] [Related]
13. Association of MMP-2 activation potential with metastatic progression in human breast cancer cell lines independent of MMP-2 production.
Azzam HS; Arand G; Lippman ME; Thompson EW
J Natl Cancer Inst; 1993 Nov; 85(21):1758-64. PubMed ID: 8411260
[TBL] [Abstract][Full Text] [Related]
14. Role of the Ha-ras (RasH) oncogene in mediating progression of the tumor cell phenotype (review).
Boylan JF; Jackson J; Steiner MR; Shih TY; Duigou GJ; Roszman T; Fisher PB; Zimmer SG
Anticancer Res; 1990; 10(3):717-24. PubMed ID: 2195986
[TBL] [Abstract][Full Text] [Related]
15. RalA requirement for v-Src- and v-Ras-induced tumorigenicity and overproduction of urokinase-type plasminogen activator: involvement of metalloproteases.
Aguirre-Ghiso JA; Frankel P; Farias EF; Lu Z; Jiang H; Olsen A; Feig LA; de Kier Joffe EB; Foster DA
Oncogene; 1999 Aug; 18(33):4718-25. PubMed ID: 10467419
[TBL] [Abstract][Full Text] [Related]
16. Activated production of metalloproteinases in Ki-ras-transformed human osteosarcoma cells.
Chan JC; Song WT
Leukemia; 1994 Apr; 8 Suppl 1():S30-5. PubMed ID: 8152301
[TBL] [Abstract][Full Text] [Related]
17. Transformation of NIH/3T3 to anchorage independence by H-ras is accompanied by loss of suppressor activity.
Tolsma SS; Cohen JD; Ehrlich LS; Bouck NP
Exp Cell Res; 1993 Apr; 205(2):232-9. PubMed ID: 8482334
[TBL] [Abstract][Full Text] [Related]
18. Purification and characterization of a bone metalloproteinase that degrades gelatin and types IV and V collagen.
Murphy G; McAlpine CG; Poll CT; Reynolds JJ
Biochim Biophys Acta; 1985 Sep; 831(1):49-58. PubMed ID: 2994741
[TBL] [Abstract][Full Text] [Related]
19. Comparison of cleavage site specificity of gelatinases A and B using collagenous peptides.
Xia T; Akers K; Eisen AZ; Seltzer JL
Biochim Biophys Acta; 1996 Apr; 1293(2):259-66. PubMed ID: 8620038
[TBL] [Abstract][Full Text] [Related]
20. Human skin fibroblast stromelysin: structure, glycosylation, substrate specificity, and differential expression in normal and tumorigenic cells.
Wilhelm SM; Collier IE; Kronberger A; Eisen AZ; Marmer BL; Grant GA; Bauer EA; Goldberg GI
Proc Natl Acad Sci U S A; 1987 Oct; 84(19):6725-9. PubMed ID: 3477804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
